Medical research

Altered cell behavior behind resistance in neuroblastoma

Researchers at Lund University in Sweden have identified one of the reasons why the childhood cancer neuroblastoma becomes resistant to chemotherapy. The findings are significant for how future treatments should be designed. ...

Neuroscience

In laboratory, scientist turns off chemo pain

In a recent paper published in the journal Pain, Saint Louis University researchers describe their success in an animal model in turning off the excruciating pain that often accompanies a colorectal cancer drug.

Oncology & Cancer

Team shows cancer chemotherapy accelerates 'molecular aging'

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists ...

Oncology & Cancer

A silver bullet to beat cancer?

The internet is awash with stories of how silver can be used to treat cancer. Now, lab tests have shown that it is as effective as the leading chemotherapy drug - and may have fewer side-effects.

Oncology & Cancer

Gut microorganisms may determine cancer treatment outcome

An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National ...

page 5 from 40